2017
DOI: 10.1182/blood-2016-12-758458
|View full text |Cite
|
Sign up to set email alerts
|

The cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiation

Abstract: As a central regulator of cell polarity, the activity of CDC42 GTPase is tightly controlled in maintaining normal hematopoietic stem and progenitor cell (HSC/P) functions. We found that transformation of HSC/P to acute myeloid leukemia (AML) is associated with increased CDC42 expression and activity in leukemia cells. In a mouse model of AML, the loss of Cdc42 abrogates -induced AML development. Furthermore, genetic ablation of CDC42 in both murine and human MLL-AF9 (MA9) cells decreased survival and induced d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
29
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 37 publications
(34 citation statements)
references
References 40 publications
(79 reference statements)
5
29
0
Order By: Relevance
“…In the context of FA, a recent study used primary BM samples from FA patients and patient-derived FA lymphoblast cell lines to demonstrate that the human FA hematopoietic cells have an intrinsic decrease in the activity of Cdc42 [25]. Another recent study shows that Cdc42 is a cell polarity determinant and controls cell division symmetry to block leukemia cell differentiation [44]. Our unpublished data indicate that FA murine HPSCs also exhibit lower Cdc42 activity compared with the WT counterparts and that Cdc42 is de-polarized in FA HSCs (unpublished data).…”
Section: Discussionmentioning
confidence: 99%
“…In the context of FA, a recent study used primary BM samples from FA patients and patient-derived FA lymphoblast cell lines to demonstrate that the human FA hematopoietic cells have an intrinsic decrease in the activity of Cdc42 [25]. Another recent study shows that Cdc42 is a cell polarity determinant and controls cell division symmetry to block leukemia cell differentiation [44]. Our unpublished data indicate that FA murine HPSCs also exhibit lower Cdc42 activity compared with the WT counterparts and that Cdc42 is de-polarized in FA HSCs (unpublished data).…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, only 2.5% (1 out of 40 mice) of cultured single SoNar-low cells from symmetrical cell divisions could initiate leukemia ( Figures S5C-S5E). Mechanistically, some genes key to symmetric (CDC42) (Mizukawa et al, 2017) or nonsymmetric cell divisions (Lis1) (Zimdahl et al, 2014) were analyzed in these cells, which showed that SoNar-high cells expressed 4.5-fold higher level of CDC42, but 2.7-fold lower level of Lis1, than that of SoNar-low cells ( Figure S5F).…”
Section: Sonar-high Aml Cells Have Enhanced Capacities Of Symmetric Dmentioning
confidence: 99%
“…Cdc42 is a Rho family small GTPase that was first discovered in Saccharomyces cerevisiae (Johnson and Pringle, 1990). It plays a role in cell migration, polarity, differentiation and proliferation, as well as branching of blood vessels and regulation of actin dynamics (Lavina et al, 2018;Melendez et al, 2013;Mizukawa et al, 2017;Nguyen et al, 2017;Schulz et al, 2015). Cdc42 is a molecular switch that cycles between active (GTP-bound) and inactive (GDPbound) states through its interaction with guanine exchange factors (GEFs) and GTPase activating proteins (GAPs) (Bishop and Hall, 2000;Schmidt and Hall, 2002).…”
Section: Introductionmentioning
confidence: 99%